1. Home
  2. JBLU vs PGEN Comparison

JBLU vs PGEN Comparison

Compare JBLU & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$5.23

Market Cap

2.1B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.66

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBLU
PGEN
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.6B
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
JBLU
PGEN
Price
$5.23
$3.66
Analyst Decision
Sell
Buy
Analyst Count
12
5
Target Price
$4.93
$7.67
AVG Volume (30 Days)
16.6M
4.2M
Earning Date
04-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
27.83
N/A
EPS
N/A
N/A
Revenue
$9,062,000,000.00
$230,981,000.00
Revenue This Year
$10.10
$342.78
Revenue Next Year
$7.91
$478.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$1.11
52 Week High
$6.53
$5.47

Technical Indicators

Market Signals
Indicator
JBLU
PGEN
Relative Strength Index (RSI) 43.12 33.80
Support Level $4.74 $3.49
Resistance Level $5.63 $5.10
Average True Range (ATR) 0.35 0.36
MACD -0.11 -0.13
Stochastic Oscillator 4.96 1.57

Price Performance

Historical Comparison
JBLU
PGEN

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: